We have updated our privacy policy. If you have any question, contact us at privacy@scicrunch.org. Dismiss and don't show again

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Modulation of glucose transporter 1 (GLUT1) expression levels alters mouse mammary tumor cell growth in vitro and in vivo.

PloS one | Aug 9, 2011

Tumor cells exhibit an altered metabolism characterized by elevated aerobic glycolysis and lactate secretion which is supported by an increase in glucose transport and consumption. We hypothesized that reducing or eliminating the expression of the most prominently expressed glucose transporter(s) would decrease the amount of glucose available to breast cancer cells thereby decreasing their metabolic capacity and proliferative potential.Of the 12 GLUT family glucose transporters expressed in mice, GLUT1 was the most abundantly expressed at the RNA level in the mouse mammary tumors from MMTV-c-ErbB2 mice and cell lines examined. Reducing GLUT1 expression in mouse mammary tumor cell lines using shRNA or Cre/Lox technology reduced glucose transport, glucose consumption, lactate secretion and lipid synthesis in vitro without altering the concentration of ATP, as well as reduced growth on plastic and in soft agar. The growth of tumor cells with reduced GLUT1 expression was impaired when transplanted into the mammary fat pad of athymic nude mice in vivo. Overexpression of GLUT1 in a cell line with low levels of endogenous GLUT1 increased glucose transport in vitro and enhanced growth in nude mice in vivo as compared to the control cells with very low levels of GLUT1.These studies demonstrate that GLUT1 is the major glucose transporter in mouse mammary carcinoma models overexpressing ErbB2 or PyVMT and that modulation of the level of GLUT1 has an effect upon the growth of mouse mammary tumor cell lines in vivo.

Pubmed ID: 21826239 RIS Download

Mesh terms: Animals | Cell Line | Cell Line, Tumor | Cell Proliferation | Female | Glucose | Glucose Transporter Type 1 | Immunoblotting | Immunohistochemistry | Mammary Neoplasms, Animal | Mice | Mice, Nude | Polymerase Chain Reaction | Pregnancy | Receptor, ErbB-2

Research resources used in this publication

None found

Research tools detected in this publication

Data used in this publication

None found

Associated grants

  • Agency: NICHD NIH HHS, Id: P01-HD38129
  • Agency: NCI NIH HHS, Id: R01 CA138482
  • Agency: NHLBI NIH HHS, Id: R01HL070070
  • Agency: NCI NIH HHS, Id: P30 CA046934
  • Agency: NICHD NIH HHS, Id: P01 HD038129
  • Agency: NIDDK NIH HHS, Id: T32 DK091317
  • Agency: NCI NIH HHS, Id: 5P30CA046934-22
  • Agency: NHLBI NIH HHS, Id: R01 HL070070

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


An Antibody supplier


View all literature mentions